Informing the consent process.

Because the legal and ethical aspects of informed consent are often foremost in clinicians’ minds, it is easy to forget that the purpose of informed consent is to aid in decision making. Informed consent forms, for example, are often written with legal and institutional priorities in mind,1 and patients in turn assume that the primary purpose of such forms is to protect physicians and their institutions.2 Indeed, it is understandable that clinicians may take little intrinsic interest in the informed consent process when seen as an external legal requirement. Article See p 21 What would happen if the informed consent process were truly seen as an opportunity for optimizing decision making? The traditional attempts at improving informed consent tend to focus only on patient outcomes, typically on whether their factual understanding or satisfaction improves. In this issue of Circulation: Cardiovascular Quality and Outcomes , Arnold and colleagues3 describe their initial experience using a Web-based individualized risk assessment tool (the Patient Refined Expectations for Deciding Invasive Cardiac Treatments [PREDICT]) as part of the informed consent process for percutaneous coronary intervention (PCI). The results of their study show that, in comparison with historical controls, patients undergoing the customized consent were in general much more involved (and perceived themselves to be so) in the consent process, and, interestingly, the customized consent seems to have affected the choice of stents used. These data …

[1]  Gabriel E. Soto,et al.  Converting the Informed Consent From a Perfunctory Process to an Evidence-Based Foundation for Patient Decision Making , 2008, Circulation. Cardiovascular quality and outcomes.

[2]  B. Gersh,et al.  Twenty-Five–Year Trends in In-Hospital and Long-Term Outcome After Percutaneous Coronary Intervention: A Single-Institution Experience , 2007, Circulation.

[3]  R. Califf,et al.  Bleeding and blood transfusion issues in patients with non-ST-segment elevation acute coronary syndromes. , 2007, European heart journal.

[4]  Robert M Califf,et al.  A comparison of the clinical impact of bleeding measured by two different classifications among patients with acute coronary syndromes. , 2006, Journal of the American College of Cardiology.

[5]  J. Spertus,et al.  Using the Risk of Restenosis as a Guide to Triaging Patients Between Surgical and Percutaneous Coronary Revascularization , 2004, Circulation.

[6]  G. Biondi-Zoccai,et al.  Radial versus femoral approach for percutaneous coronary diagnostic and interventional procedures; Systematic overview and meta-analysis of randomized trials. , 2004, Journal of the American College of Cardiology.

[7]  Á. Avezum,et al.  Predictors of hospital mortality in the global registry of acute coronary events. , 2003, Archives of internal medicine.

[8]  T. Ryan,et al.  Predicting vascular complications in percutaneous coronary interventions. , 2003, American heart journal.

[9]  E. Topol,et al.  Bivalirudin and provisional glycoprotein IIb/IIIa blockade compared with heparin and planned glycoprotein IIb/IIIa blockade during percutaneous coronary intervention: REPLACE-2 randomized trial. , 2003, JAMA.

[10]  William S Weintraub,et al.  Development of a risk adjustment mortality model using the American College of Cardiology-National Cardiovascular Data Registry (ACC-NCDR) experience: 1998-2000. , 2002, Journal of the American College of Cardiology.

[11]  D. Clair,et al.  Brave New Brain: Conquering Mental Illness in the Era of the Genome , 2002, Heredity.

[12]  E. Antman,et al.  The TIMI risk score for unstable angina/non-ST elevation MI: A method for prognostication and therapeutic decision making. , 2000, JAMA.

[13]  E W Steyerberg,et al.  Predictors of outcome in patients with acute coronary syndromes without persistent ST-segment elevation. Results from an international trial of 9461 patients. The PURSUIT Investigators. , 2000, Circulation.

[14]  B. McNeil,et al.  Measuring and improving quality of care: a report from the American Heart Association/American College of Cardiology First Scientific Forum on Assessment of Healthcare Quality in Cardiovascular Disease and Stroke. , 2000, Circulation.

[15]  B. Cassileth,et al.  Informed consent -- why are its goals imperfectly realized? , 1980, The New England journal of medicine.

[16]  H. Alpert,et al.  Hospital informed consent for procedure forms: facilitating quality patient-physician interaction. , 2000, Archives of surgery.

[17]  B. McNeil,et al.  Measuring and improving quality of care : A report from the american heart Association/American college of cardiology first scientific forum on assessment of healthcare quality in cardiovascular disease and stroke , 2000, Stroke.